Total Payments
$38,820
2024 Payments
$749.98
Companies
18
Transactions
179
Medicare Patients
7,489
Medicare Billing
$512,114
Payment Breakdown by Category
Other$23,122 (59.6%)
Consulting$6,050 (15.6%)
Food & Beverage$5,930 (15.3%)
Travel$3,691 (9.5%)
Education$26.70 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,122 | 12 | 59.6% |
| Consulting Fee | $6,050 | 2 | 15.6% |
| Food and Beverage | $5,930 | 149 | 15.3% |
| Travel and Lodging | $3,691 | 13 | 9.5% |
| Education | $26.70 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $25,208 | 32 | $0 (2024) |
| Amgen Inc. | $8,335 | 29 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,992 | 13 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $461.19 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $439.37 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $434.48 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $376.73 | 11 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $325.53 | 19 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $320.52 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $215.41 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $749.98 | 20 | Amgen Inc. ($254.79) |
| 2023 | $841.65 | 27 | Amgen Inc. ($375.63) |
| 2022 | $887.87 | 21 | Amgen Inc. ($231.20) |
| 2021 | $202.55 | 9 | Merck Sharp & Dohme Corporation ($93.12) |
| 2020 | $485.09 | 13 | AstraZeneca Pharmaceuticals LP ($180.40) |
| 2019 | $501.07 | 17 | Janssen Pharmaceuticals, Inc ($176.97) |
| 2018 | $16,369 | 20 | Novartis Pharmaceuticals Corporation ($8,871) |
| 2017 | $18,782 | 52 | Novartis Pharmaceuticals Corporation ($16,138) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $114.94 | General |
| Category: Cardiology | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/27/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $114.59 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 02/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiology | ||||||
| 02/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/22/2024 | Medicure Pharma Inc. | Zypitamag (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $122.34 | General |
| Category: Cardiology | ||||||
| 01/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $148.19 | General |
| Category: Heart Failure | ||||||
| 11/21/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Cardiology | ||||||
| 10/24/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,789 | 2,072 | $378,813 | $123,103 |
| 2022 | 24 | 1,886 | 2,228 | $413,566 | $132,815 |
| 2021 | 26 | 1,875 | 2,118 | $387,233 | $133,814 |
| 2020 | 27 | 1,939 | 2,223 | $393,363 | $122,381 |
Total Patients
7,489
Total Services
8,641
Medicare Billing
$512,114
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 326 | 385 | $38,500 | $17,260 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 267 | 302 | $30,200 | $16,145 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 159 | 203 | $30,450 | $14,172 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 116 | $17,400 | $9,298 | 53.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 169 | 180 | $54,000 | $9,012 | 16.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 68 | $19,720 | $8,965 | 45.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 36 | 40 | $34,040 | $6,957 | 20.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 12 | 15 | $25,290 | $6,198 | 24.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 81 | 81 | $38,800 | $5,833 | 15.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $10,350 | $5,299 | 51.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 43 | 43 | $9,890 | $4,402 | 44.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 50 | 55 | $6,050 | $3,408 | 56.3% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $14,370 | $3,007 | 20.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 74 | $4,440 | $2,832 | 63.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 37 | $3,885 | $2,257 | 58.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 18 | 26 | $17,212 | $2,142 | 12.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 36 | 36 | $7,800 | $1,851 | 23.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 36 | 36 | $3,060 | $958.75 | 31.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 103 | 117 | $2,925 | $711.11 | 24.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 61 | 71 | $2,556 | $678.53 | 26.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 18 | 18 | $1,476 | $359.28 | 24.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 34 | $2,380 | $357.72 | 15.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 11 | 13 | $780.00 | $355.16 | 45.5% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 17 | 19 | $1,482 | $255.42 | 17.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 11 | 11 | $737.00 | $163.10 | 22.1% |
About Dr. Michael Schoeffler, M.D
Dr. Michael Schoeffler, M.D is a Cardiovascular Disease healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912994880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Schoeffler, M.D has received a total of $38,820 in payments from pharmaceutical and medical device companies, with $749.98 received in 2024. These payments were reported across 179 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,122).
As a Medicare-enrolled provider, Schoeffler has provided services to 7,489 Medicare beneficiaries, totaling 8,641 services with total Medicare billing of $512,114. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Oklahoma City, OK
- Active Since 10/05/2005
- Last Updated 06/06/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912994880
Products in Payments
- ENTRESTO (Drug) $22,488
- Repatha (Biological) $8,221
- Resolute (Device) $1,992
- XARELTO (Drug) $461.19
- VERQUVO (Drug) $434.48
- SERELAXIN (Drug) $422.00
- Livalo (Drug) $325.53
- FARXIGA (Drug) $276.15
- ELIQUIS (Drug) $266.90
- PRALUENT ALIROCUMAB INJECTION (Biological) $258.47
- Vascepa (Drug) $215.41
- EVKEEZA (Biological) $191.22
- CAMZYOS (Drug) $172.47
- CARDIOMEMS (Device) $148.19
- LEQVIO (Drug) $126.30
- Zypitamag (Drug) $122.34
- Barostim Neo System (Device) $121.05
- Roszet (Drug) $105.00
- BRILINTA (Drug) $100.58
- NEXLETOL (Drug) $28.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Oklahoma City
Warren Jackman, Md, MD
Cardiovascular Disease — Payments: $2.5M
Cardiovascular Disease $2.5M
George Chrysant, Md, MD
Cardiovascular Disease — Payments: $559,592
Cardiovascular Disease $559,592
Dr. Riaz Sirajuddin, M.d, M.D
Cardiovascular Disease — Payments: $483,835
Cardiovascular Disease $483,835
Sunny Po, Md, MD
Cardiovascular Disease — Payments: $285,383
Cardiovascular Disease $285,383
Dr. John Summers, M.d, M.D
Cardiovascular Disease — Payments: $148,458
Cardiovascular Disease $148,458
Dwight Reynolds, Md, MD
Cardiovascular Disease — Payments: $75,986
Cardiovascular Disease $75,986